Citadel Advisors
CODX

Citadel Advisors’s Co-Diagnostics CODX Stock Holding History

Citadel Advisors’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,587
Closed -$28.3K – 13133
2025
Q4 		$28.3K Buy
5,587
+4,214
+307% +$45.9K ﹤0.01% 12242
2025
Q3 		$14.2K Sell
1,373
-810
-37% -$7.53K ﹤0.01% 12538
2025
Q2 		$18.4K Buy
2,183
+996
+84% +$9.32K ﹤0.01% 12123
2025
Q1 		$11K Buy
1,187
+327
+38% +$6.25K ﹤0.01% 13514
2024
Q4 		$19.4K Buy
860
+557
+184% +$17.6K ﹤0.01% 13202
2024
Q3 		$11.4K Buy
303
+193
+175% +$7.41K ﹤0.01% 13162
2024
Q2 		$4.13K Sell
110
-653
-86% -$23.8K ﹤0.01% 13514
2024
Q1 		$25.6K Sell
763
-1,697
-69% -$61.5K ﹤0.01% 12830
2023
Q4 		$98.2K Buy
2,460
+1,010
+70% +$35.6K ﹤0.01% 10957
2023
Q3 		$46.1K Buy
1,450
+93
+7% +$3.51K ﹤0.01% 11846
2023
Q2 		$45.2K Sell
1,357
-376
-22% -$14.4K ﹤0.01% 11921
2023
Q1 		$77K Sell
1,733
-3,117
-64% -$250K ﹤0.01% 11608
2022
Q4 		$367K Buy
4,850
+1,070
+28% +$100K ﹤0.01% 8897
2022
Q3 		$364K Sell
3,780
-807
-18% -$113K ﹤0.01% 9149
2022
Q2 		$772K Buy
4,587
+780
+20% +$119K ﹤0.01% 7618
2022
Q1 		$706K Buy
3,807
+84
+2% +$17.4K ﹤0.01% 8549
2021
Q4 		$997K Sell
3,723
-2,240
-38% -$588K ﹤0.01% 7964
2021
Q3 		$1.74M Buy
5,963
+2,550
+75% +$744K ﹤0.01% 6718
2021
Q2 		$845K Sell
3,413
-4,924
-59% -$1.27M ﹤0.01% 8788
2021
Q1 		$2.39M Buy
8,337
+564
+7% +$225K ﹤0.01% 5983
2020
Q4 		$2.17M Buy
7,773
+2,593
+50% +$961K ﹤0.01% 5190
2020
Q3 		$2.11M Sell
5,180
-1,053
-17% -$541K ﹤0.01% 4618
2020
Q2 		$3.62M Buy
6,233
+1,993
+47% +$910K ﹤0.01% 3547
2020
Q1 		$969K Buy
+4,240
New +$735K ﹤0.01% 5385

Other funds holding CODX

PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Citadel Advisors's CODX Position: Q4 2025 in Review

Citadel Advisors sold out of Co-Diagnostics (CODX) in Q4 2025, closing a stake of 353 shares — an estimated $3.84K sold.

Citadel Advisors first reported a position in CODX in Q1 2018 and held it in 25 quarters. The position peaked at $5.4M in Q2 2020. 30 funds tracked by Wall St. Rank hold CODX as of Q4 2025.

  • Citadel Advisors reported no remaining Co-Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 353 Co-Diagnostics shares in Q4 2025, an estimated $3.84K.
  • Citadel Advisors first reported a position in Co-Diagnostics in Q1 2018 and held it in 25 quarters.
  • Citadel Advisors's Co-Diagnostics position peaked at $5.4M in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.